Dynamics of High-Risk Nonvaccine Human Papillomavirus Types after Actual Vaccination Scheme

<table>Time profile of infected individuals of system (<a href="https://static.hindawi.com/articles/cmmm/volume-2014/542923/figures/#EEq1">8</a>) corresponding to different pairs of values of <svg height="7.9499998" id="M127" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 7.3375001 7.9499998" width="7.3375001" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,7.675)"><path d="M401 397q0 -24 -24 -40q-18 -13 -31 3q-36 45 -93 45q-48 0 -86.5 -43t-51.5 -112l206 6l-8 -48l-203 6v-25q0 -68 26.5 -107t73.5 -39q73 0 148 64l16 -22q-40 -44 -91 -70.5t-102 -26.5q-75 0 -116.5 45t-41.5 136q0 125 99 208q36 30 87 50.5t93 20.5q46 0 72.5 -16
t26.5 -35z" id="x1D716"></path></g>
</svg> and <svg height="8.3000002" id="M128" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 9.7250004 8.3000002" width="9.7250004" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,8.038)"><path d="M548 455q-32 -77 -74 -77q-37 0 -103 10l-3 -2q36 -30 48.5 -62t12.5 -80q0 -103 -75 -179.5t-175 -76.5q-70 0 -113 45t-43 128q0 115 83.5 200.5t209.5 85.5q31 0 77.5 -4t67.5 -4q36 0 62 30zM350 274q0 54 -17 86q-19 35 -57 35q-50 0 -90 -37.5t-59 -91.5t-19 -109
q0 -61 24.5 -96.5t65.5 -35.5q51 0 87.5 46.5t50.5 100.5t14 102z" id="x1D70E"></path></g>
</svg>. These simulations suggest that if the effectiveness of cross-protective immunity is not larger than the effectiveness of the vaccine, then the high-risk nonvaccine-type HPV emerge.</table>

Computational and Mathematical Methods in Medicine

fig2

Figure 2

Figure 2: Dynamics of High-Risk Nonvaccine Human Papillomavirus Types after Actual Vaccination Scheme 